Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋水仙素是不恰当，很少有炎症能超过急性足痛风了，并且秋水仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受秋水仙碱治疗效果不明显转而受氨苯砜治疗当继续服用秋水仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服仙素是不恰当的，很少有炎症能性足痛风的病人了，并且仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受仙碱治疗效果不明显转而受氨苯砜治疗的患者应当继续服仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋水仙素是恰当的，很少有炎症能超过急性足痛风的病人了，并且秋水仙素能导致。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

此，我么你建议，在开始受秋水仙碱治疗效果转而受氨苯砜治疗的患者应当继续服用秋水仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋水仙素是不恰，少有炎症能超过急性足痛风病人了，并且秋水仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受秋水仙碱治疗效果不明显转而受氨苯砜治疗患者应继续服用秋水仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋水仙素当的，很少有炎症能超过急足痛风的病人了，并且秋水仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受秋水仙碱治疗效果明显转而受氨苯砜治疗的患者应当继续服用秋水仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋水仙素是不恰当的，很少有炎症超过急性足痛风的病人了，并且秋水仙素腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受秋水仙碱治疗效果不明显受氨苯砜治疗的患者应当继续服用秋水仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋水仙素是不恰当的，很有症能超过急性足痛风的病人了，并且秋水仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受秋水仙碱治疗效果不显转而受氨苯砜治疗的患者应当继续服用秋水仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋水仙素是不恰当的，很少有炎症能超过急性足痛风的病人了，并且秋水仙素能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始受秋水仙碱治疗效果不明显转而受氨苯砜治疗的患者应当继续服用秋水仙碱。

Oral colchicine would be inappropriate;there are few patients angrier than those with acute podagra and colchicine-induced diarrhea.

口服秋是不恰当的，很少有炎症能超过急性足痛风的病人了，并且秋能导致腹泻。

Thus, we suggest that patients whose complex aphthosis does not respond to colchicine in their initial therapeutic trial continue taking colchicine when dapsone is added to the regimen.

因此，我么你建议，在开始秋碱治疗效果不明显转而砜治疗的患者应当继续服用秋碱。